Statistics for Subcutaneous engineered factor VIIa marzeptacog alfaactivated n hemophilia with inhibitorsPhase 2 trial of pharmacokinetics pharmacodynamics efficacy and safety
Total visits
| views | |
|---|---|
| Subcutaneous engineered factor VIIa marzeptacog alfaactivated n hemophilia with inhibitorsPhase 2 trial of pharmacokinetics pharmacodynamics efficacy and safety | 5 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| Journal.pdf | 22 |
Top country views
| views | |
|---|---|
| India | 3 |
| South Africa | 2 |
Top city views
| views | |
|---|---|
| Hyderabad | 2 |
| Johannesburg | 1 |
| Midrand | 1 |
| Mumbai | 1 |